Page 27 - MemoriaDEM-Eng

www.ciberdem.org

3500

3000

2500

2000

1500

Muestras
1000
Biobanco

500

0
DM1 DM2 OB OM
DL DG MODY [email protected]

METABOLOMICS PLATFORM

http://www.ciberdem.org/metabolomica.php

The Metabolomics Platform is a technological service platform created by the Uni-

versitat Rovira i Virgili (hereinafter URV) and the Centro de Investigación Biomé-

dica en Red de Diabetes y Enfermedades Metabólicas (hereinafter CIBERDEM) by
means of a collaboration agreement.

The main objective of the Metabolomics Platform is to work as an integrated labo-

ratory, i.e., as a consultation point directly involved in metabolomics-related expe-

riments proposed by the research groups. Our collaborations start with defining the
objectives, dimension and characteristics of both the sample set and experiment

designs. After that, the data is processed by our team and we are involved in the
interpretation of results, delivering sound, significant and useful clinical conclusions

for the different research groups.

The equipment currently available in the field of NMR and MS (GC-single quad,

LC-TOF and LCQqQ) allows large-scale measurements of body fluids, for example,
serum or urine, as well as tissues or biopsies from humans and/or animal models

(such as rats, mice, etc).
13
The use of advanced statistics, chemometrics, multivariate and artificial-intelligen- 20
ce algorithms allows transforming a large dataset into metabolic fingerprints or T
OR
continuous result profiles, and ultimately into clinical information. Our goal is to P
RE
introduce metabolomics as a potential tool for clinical diagnostics and to clarify L
unknown mechanisms of associated diseases.
A
NU
The Metabolomics Platform particularly focuses on the needs of CIBERDEM and N
A
URV research groups. However, its services and potential scientific collaborations M /
E
are available to other biomedical research groups both in Spain and abroad.
D
ER
B
CI

27